Suppr超能文献

基于纳米材料的血脑屏障(BBB)穿越策略。

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

机构信息

Jiangsu Key Laboratory of Molecular Imaging and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, 210009, China; Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, 3-25-14, Tonomachi, Kawasaki-ku, Kawasaki, 210-0821, Japan.

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, 20892, USA.

出版信息

Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.

Abstract

Increasing attention has been paid to the diseases of central nervous system (CNS). The penetration efficiency of most CNS drugs into the brain parenchyma is rather limited due to the existence of blood-brain barrier (BBB). Thus, BBB crossing for drug delivery to CNS remains a significant challenge in the development of neurological therapeutics. Because of the advantageous properties (e.g., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseases. This review summarizes the current understanding of the physiological structure of BBB, and provides various nanomaterial-based BBB-crossing strategies for brain delivery of theranostic agents, including intranasal delivery, temporary disruption of BBB, local delivery, cell penetrating peptide (CPP) mediated BBB-crossing, receptor mediated BBB-crossing, shuttle peptide mediated BBB-crossing, and cells mediated BBB-crossing. Clinicians, biologists, material scientists and chemists are expected to be interested in this review.

摘要

人们越来越关注中枢神经系统(CNS)疾病。由于存在血脑屏障(BBB),大多数 CNS 药物进入脑实质的穿透效率相当有限。因此,对于 CNS 递药来说,BBB 穿越仍然是神经治疗学发展中的一个重大挑战。由于具有有利的性质(例如,相对较高的药物装载含量、可控的药物释放、出色的被动和主动靶向、良好的稳定性、生物降解性、生物相容性和低毒性),具有 BBB 穿越能力的纳米材料已被广泛开发用于治疗 CNS 疾病。本文综述了对 BBB 生理结构的现有认识,并提供了各种基于纳米材料的 BBB 穿越策略,用于治疗剂的脑内递药,包括鼻内递药、BBB 暂时破坏、局部递药、细胞穿透肽(CPP)介导的 BBB 穿越、受体介导的 BBB 穿越、穿梭肽介导的 BBB 穿越和细胞介导的 BBB 穿越。临床医生、生物学家、材料科学家和化学家有望对这篇综述感兴趣。

相似文献

1
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.
3
Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1695. doi: 10.1002/wnan.1695. Epub 2021 Jan 20.
4
Strategies for transporting nanoparticles across the blood-brain barrier.
Biomater Sci. 2016 Feb;4(2):219-29. doi: 10.1039/c5bm00383k.
5
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.
Adv Mater. 2018 Nov;30(46):e1801362. doi: 10.1002/adma.201801362. Epub 2018 Jul 31.
6
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
CNS Drugs. 2017 Feb;31(2):109-133. doi: 10.1007/s40263-016-0405-9.
7
Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers.
Int J Nanomedicine. 2024 Nov 21;19:12343-12368. doi: 10.2147/IJN.S497480. eCollection 2024.
8
The blood-brain barriers: novel nanocarriers for central nervous system diseases.
J Nanobiotechnology. 2025 Feb 26;23(1):146. doi: 10.1186/s12951-025-03247-8.
9
Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.
ACS Nano. 2024 Jan 23;18(3):1820-1845. doi: 10.1021/acsnano.3c10674. Epub 2024 Jan 9.
10
Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
Handb Exp Pharmacol. 2024;284:213-230. doi: 10.1007/164_2023_689.

引用本文的文献

1
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases.
MedComm (2020). 2025 Sep 12;6(9):e70386. doi: 10.1002/mco2.70386. eCollection 2025 Sep.
2
Biomimetic membrane nanotechnology in cerebral ischemic stroke:a promising technology for therapeutic treatment and diagnosis.
Front Bioeng Biotechnol. 2025 Aug 20;13:1605377. doi: 10.3389/fbioe.2025.1605377. eCollection 2025.
3
Lipid nanoparticles for mRNA delivery in brain via systemic administration.
Sci Adv. 2025 Aug 15;11(33):eadw0730. doi: 10.1126/sciadv.adw0730. Epub 2025 Aug 13.
4
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges.
Asian J Pharm Sci. 2025 Aug;20(4):101060. doi: 10.1016/j.ajps.2025.101060. Epub 2025 Apr 21.
5
Pharmacokinetics and tissue distribution analysis of ginsenoside Rh in rats using a novel LC-MS/MS quantification strategy.
Front Pharmacol. 2025 Jul 10;16:1582644. doi: 10.3389/fphar.2025.1582644. eCollection 2025.
6
Harnessing Organoid Platforms for Nanoparticle Drug Development.
Drug Des Devel Ther. 2025 Jul 18;19:6125-6143. doi: 10.2147/DDDT.S530999. eCollection 2025.
7
Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery.
RSC Adv. 2025 Jul 21;15(32):25910-25928. doi: 10.1039/d5ra03578c.
8
Evolution of glioma exosome research: emerging trends and global collaborations (2005-2025).
Discov Oncol. 2025 Jul 16;16(1):1345. doi: 10.1007/s12672-025-03167-x.
9
Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier.
J Nanobiotechnology. 2025 Jul 8;23(1):493. doi: 10.1186/s12951-025-03572-y.
10
Development of blood-brain barrier-penetrating antibodies for neutralizing tick-borne encephalitis virus in the brain.
mSphere. 2025 Jul 29;10(7):e0018425. doi: 10.1128/msphere.00184-25. Epub 2025 Jul 7.

本文引用的文献

1
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Chem Soc Rev. 2019 Jun 4;48(11):2967-3014. doi: 10.1039/c8cs00805a.
3
Low-intensity focused ultrasound for the treatment of brain diseases: safety and feasibility.
Theranostics. 2019 Jan 1;9(2):537-539. doi: 10.7150/thno.31765. eCollection 2019.
5
Local Delivery of Brain-Derived Neurotrophic Factor Enables Behavioral Recovery and Tissue Repair in Stroke-Injured Rats.
Tissue Eng Part A. 2019 Aug;25(15-16):1175-1187. doi: 10.1089/ten.TEA.2018.0215. Epub 2019 Feb 27.
6
Kojic acid applications in cosmetic and pharmaceutical preparations.
Biomed Pharmacother. 2019 Feb;110:582-593. doi: 10.1016/j.biopha.2018.12.006. Epub 2018 Dec 8.
7
Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors.
ACS Nano. 2018 Nov 27;12(11):11355-11365. doi: 10.1021/acsnano.8b06201. Epub 2018 Nov 5.
8
Receptor-Targeted Glial Brain Tumor Therapies.
Int J Mol Sci. 2018 Oct 25;19(11):3326. doi: 10.3390/ijms19113326.
9
Getting cancer drugs into the brain.
Nature. 2018 Sep;561(7724):S46-S47. doi: 10.1038/d41586-018-06707-4.
10
Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications.
Acta Pharm Sin B. 2018 Sep;8(5):733-755. doi: 10.1016/j.apsb.2018.07.011. Epub 2018 Jul 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验